“And then, after the moment he was shot, he had a mild fever again, then everything was fine, he felt good and he has a large number [of antibodies],” Putin said. (Representative image: Reuters) President Vladimir Putin announced Tuesday that Russia has developed the world’s first vaccine opposed to COVID-19 that works “quite effectively” and the bureaucracy a “stable immunity” opposed to the deadly disease by revealing that one of its daughters has already been vaccinated.
“A coronavirus vaccine first recorded in the world this morning,” Putin said in an assembly with members of his government.
“I know it works effectively, bureaucracy is a solid immunity,” Putin said, as quoted through the official Tass news agency.
Putin’s statement follows the considerations expressed through experts about the speed of Russia’s work, suggesting that researchers would likely be taking shortcuts.
In reaction to Putin’s announcement, U.S. Health Secretary Alex Azar said the purpose of creating a coronavirus vaccine was not to be the first, but still to have one that was effective.
“The point is not to be the first to receive a vaccine, the purpose is to have a vaccine that is effective for other Americans and the rest of the world,” Azar told ABC News.
“We want transparent knowledge, and it will have to be a phase 3 knowledge that proves that a vaccine is effective,” Azar said, recently on a historic scale in Taiwan.
Danny Altmann, professor of immunology at Imperial College London, told the Science Media Center that there were considerations about the release of a vaccine before it was fully tested.
“The bar is necessarily very high for the criteria that will need to be met for approval after phase 3 clinical trials,” Altmann said, citing CNN.
Amid fears that security has been compromised, the World Health Organization (WHO) last week suggested that Russia adhere to foreign rules for the production of a vaccine opposed to COVID-19, the BBC reported.
The Russian vaccine is on WHO’s list of six vaccines that have reached phase 3 of clinical trials, which involve more widespread human testing, according to the report.
But Putin said one of his daughters had tried on a Russian COVID-19 vaccine in itself and that she felt good.
“I know very well, because one of my daughters was sucked, so in that sense she took part in the tests,” Putin said. He did not specify which of his two daughters had won the vaccine.
The vaccine is called Sputnik-V. The call refers to the wonderful launch in 1957 of the world’s first satellite across the Soviet Union.
The remedy has not yet been the subject of very important phase 3 trials in which thousands of people would be administered.
President Putin noted that after the first vaccine, his daughter had a 38-degree fever and, the next day, a fever above 37 degrees Celsius.
“And then, after the moment he was shot, he had a mild fever again, then everything was fine, he felt good and he has a large number [of antibodies],” Putin said.
Russian Health Minister Mikhail Murashko said vaccine trials developed through the National Center for Research on Epidemiology and Microbiology of the Russian Ministry of Health have been completed.
Doctors and teachers will be the first to get the COVID-19 vaccine, he said.
“We will begin civil use step by step of the vaccine. Above all, we need to offer vaccination to those who come into contact with other people who are inflamed at work. They’re medical workers. And also to those who are guilty of the fitness of children — teachers, ” said the minister.
The vaccine has two injected parts that together deserve to build long-term immunity against the virus, Sputniknews reported.
Clinical trials of the vaccine began on June 18 and included 38 volunteers. All participants developed immunity. The first organization launched on July 15, the organization of the moment on July 20.
It will be in flux from January 1, 2021, the National Register of Pharmaceutical Products reported on Tuesday.
“Date of introduction to civilian – 01.01.2021,” the website notes.
The Gamaleya Centre has been reported to have developed two vaccine bureaucracies: one liquid and one freeze-dried.
Health Minister Murashko said the coronavirus infection vaccine will occur in Russia at two sites.
Russia won a request to produce one billion doses of the COVID-19 vaccine from 20 states, Kirill Dmitriev, director of the Russian Direct Investment Fund (RDIF), said at a conference.
“We have won initial applications to acquire more than one billion doses of vaccines from 20 states. We are able to produce over 500 million doses of vaccines with our foreign partners in five countries, and we plan to further increase our production capacity,” he said.
According to Dmitriev, several states in Latin America, the Middle East and Asia have expressed interest in the Russian vaccine. Several contracts have been terminated.
It noted that RDIF had agreed to conduct the third level of clinical trials of the COVID-19 vaccine with the United Arab Emirates, Saudi Arabia and other states.
According to Johns Hopkins University, coronavirus has inflamed more than 20 million people and killed more than 737,000 people worldwide.
Get live equity costs from BSE, NSE, U.S. market. And the latest liquidity value, mutual fund portfolio, calculate your taxes, the source of the income tax calculator, meet the most productive winners on the market, the most productive losers and the most productive equity funds. Like it on Facebook and stay with us on Twitter.
Financial Express is now on Telegram. Click here to register on our channel and stay up to date with the latest News and Updates from Biz.